IFG Advisory’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.52K Hold
300
– – ﹤0.01% 1888
2026
Q2
$7.61K Buy
+300
New +$7.09K ﹤0.01% 1898

Other funds holding PCRX

IFG Advisory's PCRX Position: Q3 2026 in Review

IFG Advisory held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 300 shares worth $7.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

IFG Advisory first reported a position in PCRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $7.61K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • IFG Advisory held 300 shares of Pacira BioSciences worth $7.52K as of Q3 2026.
  • IFG Advisory left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of IFG Advisory's portfolio in Q3 2026, its #1888 holding.
  • IFG Advisory first reported a position in Pacira BioSciences in Q2 2026 and has held it in 2 quarters since.
  • IFG Advisory's Pacira BioSciences position peaked at $7.61K in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.